Series: Ask the IRB & IBC Experts
WCG’s IRB & IBC Review professionals get questions about clinical research all the time: from researchers, clinical team members at biopharma companies, and from members of institutional IRBs. We know that for many of the questions, the person asking is not the only one struggling with that issue. We’ve built this forum as an immediate and less formal way to share information across the clinical research community.
Series: Ask the IRB & IBC Experts
What Is the Accelerated Approval Pathway? Understanding the Latest FDA Guidance
Blog Posts
Biosafety
What Is a Biological Safety Cabinet? Do We Need One to Prepare Our Gene Therapy Product?
Blog Posts
Ethics in Clinical Research
How Do PIs Report PRI in a Blinded Study Without Unblinding Themselves?
Blog Posts
Ethics in Clinical Research
Do You Need to Submit an Updated Protocol to the IBC After Already Receiving Approval?
Blog Posts
Ethics in Clinical Research
Answering FAQs on HIPAA & PHI: Protect Participants’ Privacy & Ensure Compliance
Blog Posts
Regulatory Compliance
Why do Community Members Need to Participate in IBC Review Meetings?
Blog Posts
Series: Ask the IRB & IBC Experts
If a site needs to submit to create an IBC with WCG, how long does the NIH registration process typically take?
Blog Posts
Series: Ask the IRB & IBC Experts
Does my clinic need to have an Exposure Control Plan in place?
Blog Posts
Ethics in Clinical Research
What Is Exempt Research?
Blog Posts
Ethics in Clinical Research